Page 28 - Binder1

Bibliography

1. Kushi, L.H., et al., American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA: A Cancer Journal for
Clinicians, 2012. 62(1): p. 30‐67.
2. Floor, S.L., et al., Hallmarks of cancer: of all cancer cells, all the time? Trends in Molecular Medicine, 2012. 18(9): p. 509‐515.
3. Hanahan, D. and R.A. Weinberg, The Hallmarks of Cancer. Cell, 2000. 100(1): p. 57‐70.
4. Hanahan, D. and Robert A. Weinberg, Hallmarks of Cancer: The Next Generation. Cell, 2011. 144(5): p. 646‐674.
5. Nathan, C., Points of control in inflammation. Nature, 2002. 420(6917): p. 846‐852.
6. Mantovani, A., et al., Cancer‐related inflammation. Nature, 2008. 454(7203): p. 436‐444.
7. Colotta, F., et al., Cancer‐related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 2009. 30(7): p.1073‐1081.
8. Serhan, C.N., et al., Resolution of inflammation: state of the art, definitions and terms. The FASEB Journal, 2007. 21(2): p. 325‐332.
9. Balkwill, F. and A. Mantovani, Inflammation and cancer: back to Virchow? The Lancet, 2001. 357(9255): p. 539‐545.
10. Philip, M., D.A. Rowley, and H. Schreiber, Inflammation as a tumor promoter in cancer induction. Seminars in Cancer Biology, 2004. 14(6): p. 433‐439.
11. Maskrey, B.H., et al., Emerging importance of omega‐3 fatty acids in the innate immune response: Molecular mechanisms and lipidomic strategies for their
analysis. Molecular Nutrition & Food Research, 2013. 57(8): p. 1390‐1400.
12. Candido, J. and T. Hagemann, Cancer‐related inflammation. J Clin Immunol, 2013. 33 Suppl 1(1): p. S79‐84.
13. Ben‐Baruch, A., Inflammation‐associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators. Seminars in
Cancer Biology, 2006. 16(1): p. 38‐52.
14. Faber, J., et al., Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving
radiotherapy, a randomized trial. Clin Nutr, 2013. 32(3): p. 338‐45.
15. Wang, D. and R.N. DuBois, Eicosanoids and cancer. Nat Rev Cancer, 2010. 10(3): p. 181‐193.
16. Allen, N.E., et al., Serum Insulin‐like Growth Factor (IGF)‐I and IGF‐Binding Protein‐3 Concentrations and Prostate Cancer Risk: Results from the European
Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology Biomarkers & Prevention, 2007. 16(6): p. 1121‐1127.
17. Patel, A.V., et al., Obesity, Recreational Physical Activity, and Risk of Pancreatic Cancer In a Large U.S. Cohort. Cancer Epidemiology Biomarkers &
Prevention, 2005. 14(2): p. 459‐466.
18. Grivennikov, S.I., F.R. Greten, and M. Karin, Immunity, Inflammation, and Cancer. Cell, 2010. 140(6): p. 883‐899.
19. Kawachi, S., et al., Role of inducible nitric oxide synthase in the regulation of VCAM‐1 expression in gut inflammation. American Journal of Physiology ‐
Gastrointestinal and Liver Physiology, 1999. 277(3): p. G572‐G576.
20. Condeelis, J. and J.W. Pollard, Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis. Cell, 2006. 124(2): p. 263‐266.

www.complementarycancerresearch.org